| The shifting interface between IBS and IBD. | |
| | |
MedLine Citation:
|
PMID: 22000604 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Recent data developing from the study of postinfectious IBS has challenged the belief that IBS is a purely psychological disorder. Distinct abnormalities of the gut mucosa have been reported including immune activation and increased release of inflammatory mediators with some overlap with IBD. New studies show that genetic factors which predispose to IBD are also associated with IBS. A common feature is impaired gut barrier function which appears to precede the development of IBD while in IBS it may be the result of either a preceding infection or psychosocial stress. Stress can activate mast cells which are a feature in most but not all IBS series. Anti-inflammatory treatments targeting activated mast cells may benefit IBS patients but currently the evidence is weak and larger trials are needed. Changes in the commensal microbiota have been recently described with a "dysbiosis" in CD characterised by reduced diversity. Inconsistent changes have also been described in IBS but studies controlling for antibiotic use and differences in diet and bowel habit are needed before definitive conclusions can be made. |
| | |
Authors:
|
Robin Spiller; Ching Lam |
Related Documents
:
|
6341004 - The anaemia of plasmodium falciparum malaria. 16179034 - Have gastrointestinal nematodes outwitted the immune system? 21063114 - Schistosoma mansoni soluble egg antigens trigger erythrocyte cell death. 14699044 - Il-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host surv... 20689824 - The effect of leflunomide on cycling and activation of t-cells in hiv-1-infected partic... 9439384 - Th1/th2 cytokine profiles in the nasopharyngeal lymphoid tissues of children with recur... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-10-13 |
Journal Detail:
|
Title: Current opinion in pharmacology Volume: - ISSN: 1471-4973 ISO Abbreviation: - Publication Date: 2011 Oct |
Date Detail:
|
Created Date: 2011-10-17 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100966133 Medline TA: Curr Opin Pharmacol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 Elsevier Ltd. All rights reserved. |
Affiliation:
|
NIHR Biomedical Research Unit, Nottingham Digestive Diseases Centre, University Hospital, Nottingham NG7 2UH, United Kingdom. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Spatial control of cAMP signalling in health and disease.
Next Document: Achieving translation in models of visceral pain.